Awasthi, A. ., Rolland, D. ., Ayello, J. ., van de Ven, C. ., , Conlon, K. ., … Cairo, M. . (2017). A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment. Oncotarget, 8(69), 113895-113909. https://doi.org/10.18632/oncotarget.23040 (Original work published 2017)